Alpha-synuclein in Parkinson's disease: Embracing debate, exercising skepticism.
Saved in:
| Title: | Alpha-synuclein in Parkinson's disease: Embracing debate, exercising skepticism. |
|---|---|
| Authors: | Espay AJ; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA. Electronic address: aespay@gmail.com., Lees AJ; The National Hospital, Queen Square and Reta Lila Weston Institute for Neurological Studies University College London, London, UK., Cardoso F; Movement Disorders Unit, Neurology Service, Internal Medicine Department, The Federal University of Minas Gerais, Belo Horizonte, Brazil., Frucht SJ; The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University Langone Health, New York, NY, USA., Erskine D; Translational and Clinical Research Institute, Newcastle University, UK., Sturchio A; James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA; Neuro Svenningsson, Department of Clinical Neuroscience, Karolinska Institute, SE-171 76, Stockholm, Sweden., Imarisio A; Department of Molecular Medicine, University of Pavia, 27100, Pavia, Italy; Neurogenetics Research Centre, IRCCS Mondino Foundation, 27100, Pavia, Italy., Hoffmann C; Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany., Montemagno KT; Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark., Naudi-Fabra S; Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany., Milovanovic D; Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Einstein Center for Neuroscience, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, and Berlin Institute of Health, 10117, Berlin, Germany., Halliday GM; School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, 2050, Australia., Manfredsson FP; Department of Translational Neuroscience and the Muhammad Ali Parkinson Center, Barrow Neurological Institute, Phoenix, AZ, USA. |
| Source: | Parkinsonism & related disorders [Parkinsonism Relat Disord] 2025 Jul; Vol. 136, pp. 107874. Date of Electronic Publication: 2025 May 15. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5126 (Electronic) Linking ISSN: 13538020 NLM ISO Abbreviation: Parkinsonism Relat Disord Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
